Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Sepriano

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Annals of the Rheumatic Diseases|December 10, 2023
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclatureDésirée van der Heijde, Anna Molto, Sofia Ramiro, et al.
Acta Reumatologica Portuguesa|September 13, 2017
The Portuguese Society of Rheumatology position paper on the use of biosimilars - 2017 updateFilipe C Araújo, Alexandre Sepriano, Filipa Teixeira, et al.
Annals of the Rheumatic Diseases|October 30, 2025
EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritisHelena Marzo-Ortega, Stephanie R Harrison, George E Fragoulis, et al.
Rheumatology (Oxford, England)|January 16, 2023
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAMSofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
The Journal of Rheumatology|September 17, 2019
Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM CohortAlexandre Sepriano, Sofia Ramiro, Oliver FitzGerald, et al.
Annals of the Rheumatic Diseases|January 15, 2017
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritisDésirée van der Heijde, Sofia Ramiro, Robert Landewé, et al.
Annals of the Rheumatic Diseases|February 26, 2020
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)Sofia Ramiro, Robert Bm Landewé, Désirée van der Heijde, et al.
The Journal of Rheumatology|September 3, 2019
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RAWalter P Maksymowych, Oliver FitzGerald, Mikkel Østergaard, et al.
Annals of the Rheumatic Diseases|July 6, 2026
Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS projectSofia Ramiro, Dafne Capelusnik, Clementina López-Medina, et al.
Annals of the Rheumatic Diseases|October 21, 2022
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 updateSofia Ramiro, Elena Nikiphorou, Alexandre Sepriano, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Annals of the Rheumatic Diseases|December 10, 2023
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclatureDésirée van der Heijde, Anna Molto, Sofia Ramiro, et al.
Acta Reumatologica Portuguesa|September 13, 2017
The Portuguese Society of Rheumatology position paper on the use of biosimilars - 2017 updateFilipe C Araújo, Alexandre Sepriano, Filipa Teixeira, et al.
Annals of the Rheumatic Diseases|October 30, 2025
EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritisHelena Marzo-Ortega, Stephanie R Harrison, George E Fragoulis, et al.
Rheumatology (Oxford, England)|January 16, 2023
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAMSofia Ramiro, Robert Landewé, Désirée van der Heijde, et al.
The Journal of Rheumatology|September 17, 2019
Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM CohortAlexandre Sepriano, Sofia Ramiro, Oliver FitzGerald, et al.
Annals of the Rheumatic Diseases|January 15, 2017
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritisDésirée van der Heijde, Sofia Ramiro, Robert Landewé, et al.
Annals of the Rheumatic Diseases|February 26, 2020
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)Sofia Ramiro, Robert Bm Landewé, Désirée van der Heijde, et al.
The Journal of Rheumatology|September 3, 2019
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RAWalter P Maksymowych, Oliver FitzGerald, Mikkel Østergaard, et al.
Annals of the Rheumatic Diseases|July 6, 2026
Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS projectSofia Ramiro, Dafne Capelusnik, Clementina López-Medina, et al.
Annals of the Rheumatic Diseases|October 21, 2022
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 updateSofia Ramiro, Elena Nikiphorou, Alexandre Sepriano, et al.
Pageof 13